13 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PHOSPHORUS-SL ASSAY, CATALOGUE NUMBER 117-10, 117-30

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

ACE OPEN-BACK HALO RING

FDA 510(k)
FDA Class 2 ·Orthopedic

LASERTRIPTER MINISCOPE

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

PSO KNEE BONE SUBSTITUTION

FDA Adverse Event
Injury ·BIOMET SPAIN, S.L.·Product code KRO·April 22, 2022

PSO KNEE BONE SUBSTITUTION

FDA Adverse Event
Injury ·BIOMET SPAIN, S.L.·Product code KRO·July 18, 2019

MORPHEUS PICC

FDA Adverse Event
Malfunction ·ANGIODYNAMICS·Product code LJS·June 11, 2014

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·February 22, 2013

PRECISION TEST STRIPS

FDA Adverse Event
Malfunction ·ABBOTT DIABETES CARE, INC. USA·Product code NBW·January 31, 2011

UNKNOWN HEAD

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·February 16, 2018

NFORCE NITINOL HELICAL STONE EXTRACTOR

FDA Adverse Event
Malfunction ·COOK INC·Product code FFL·June 13, 2019

BioButton REF BIOST06040 with Software version 3.0.20 The BioButton System is a remote monitoring wearable device intended for continuous collection of physiological data in home and healthcare settings while the patient is at rest.

FDA Enforcement
Class II ·Ongoing·Biointellisense Inc.·August 21, 2024

Exactech Equinoxe REVERSE SHOULDER,36mm Humeral Liner: a) +0mm, Item Number 320-36-00, b) +2.5mm, Item Number 320-36-03; Shoulder Arthroplasty

FDA Enforcement
Class II ·Ongoing·Exactech, Inc.·April 10, 2024

Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017